Literature DB >> 15845483

Immunological and protective effects of diepitopic subunit dental caries vaccines.

Daniel J Smith1, William F King, Joy Rivero, Martin A Taubman.   

Abstract

As a prelude to development of broader-spectrum vaccines for dental caries, we explored the immune potential of constructs combining epitopes from mutans streptococcal glucosyltransferases (GTF) and glucan binding protein B (GbpB). Two diepitopic peptide constructs were synthesized in a multiple antigenic peptide (MAP) format. Both constructs contained SYI, a 20-mer GbpB peptide that included a sequence having major histocompatibility complex class II binding characteristics. One diepitopic construct (SYI-CAT) also contained a 22-mer sequence from the catalytic domain of GTF. Another diepitopic construct (SYI-GLU) contained a 22-mer sequence from the glucan binding domain of GTF. To assess the ability of each construct to induce antibody reactive with GbpB and GTF native proteins, rats were injected subcutaneously with SYI-CAT, SYI-GLU, or the constituent monoepitopic constructs. Only the SYI-CAT construct induced significant levels of serum immunoglobulin G (IgG) and IgA antibody to both pathogenesis-associated proteins. Also, immunization with SYI-CAT significantly (P < 0.001) enhanced the antibody response to the CAT peptide. Experiments then compared experimental dental caries after immunization with SYI-CAT, SYI, or CAT MAP constructs, followed by infection with Streptococcus mutans strain SJr. Dental caries were lower in each peptide-immunized group than in the sham-injected group. The level of protection after SYI-CAT immunization was similar to that after immunization with constituent MAP constructs. In another experiment, rats were infected with Streptococcus sobrinus strain 6715 under an identical protocol. Significant protection was observed on buccal surfaces in both SYI-CAT and CAT construct-immunized, but not in the SYI construct-immunized, groups. Thus, addition of the GbpB-derived SYI peptide to the GTF-derived CAT peptide construct not only enhanced the immunological response to CAT and GTF epitopes, but also extended the protective effect of the construct to include both S. mutans and S. sobrinus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845483      PMCID: PMC1087357          DOI: 10.1128/IAI.73.5.2797-2804.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Glucan-binding proteins of the oral streptococci.

Authors:  J A Banas; M M Vickerman
Journal:  Crit Rev Oral Biol Med       Date:  2003

2.  Isolation of a glucan-binding domain of glucosyltransferase (1,6-alpha-glucan synthase) from Streptococcus sobrinus.

Authors:  G Mooser; C Wong
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

3.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Peptide sequences for sucrose splitting and glucan binding within Streptococcus sobrinus glucosyltransferase (water-insoluble glucan synthetase).

Authors:  H Abo; T Matsumura; T Kodama; H Ohta; K Fukui; K Kato; H Kagawa
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

5.  Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase.

Authors:  D J Smith; M A Taubman; W F King; S Eida; J R Powell; J Eastcott
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Purification and antigenicity of a novel glucan-binding protein of Streptococcus mutans.

Authors:  D J Smith; H Akita; W F King; M A Taubman
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Molecular genetic analysis of the catalytic site of Streptococcus mutans glucosyltransferases.

Authors:  C Kato; Y Nakano; M Lis; H K Kuramitsu
Journal:  Biochem Biophys Res Commun       Date:  1992-12-15       Impact factor: 3.575

8.  Isolation and sequence of an active-site peptide containing a catalytic aspartic acid from two Streptococcus sobrinus alpha-glucosyltransferases.

Authors:  G Mooser; S A Hefta; R J Paxton; J E Shively; T D Lee
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

9.  Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyltransferase.

Authors:  D J Smith; M A Taubman; C F Holmberg; J Eastcott; W F King; P Ali-Salaam
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

10.  Construction and immunogenic characterization of a fusion anti-caries DNA vaccine against PAc and glucosyltransferase I of Streptococcus mutans.

Authors:  J H Guo; R Jia; M W Fan; Z Bian; Z Chen; B Peng
Journal:  J Dent Res       Date:  2004-03       Impact factor: 6.116

View more
  6 in total

1.  Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans.

Authors:  Ying Sun; Yi Yang; Dihan Zhou; Yuan Cao; Jie Yu; Bali Zhao; Maohua Zhong; Yaoming Li; Jingyi Yang; Huimin Yan
Journal:  Hum Vaccin Immunother       Date:  2016-07-08       Impact factor: 3.452

2.  Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents.

Authors:  Xi-Xi Cao; Yu-Hong Li; Qian-Lin Ye; Xuan Hu; Tian-Feng Wang; Ming-Wen Fan
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 3.  The oral microbiome and the immunobiology of periodontal disease and caries.

Authors:  Massimo Costalonga; Mark C Herzberg
Journal:  Immunol Lett       Date:  2014-11-08       Impact factor: 3.685

4.  Immunogenic and protective potential of mutans streptococcal glucosyltransferase peptide constructs selected by major histocompatibility complex class II allele binding.

Authors:  S Culshaw; K Larosa; H Tolani; X Han; J W Eastcott; D J Smith; M A Taubman
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

5.  Lab-Test(®) 4: Dental caries and bacteriological analysis.

Authors:  Francesca Cura; Annalisa Palmieri; Ambra Girardi; Marcella Martinelli; Luca Scapoli; Francesco Carinci
Journal:  Dent Res J (Isfahan)       Date:  2012-12

6.  Investigating the candidacy of the serotype specific rhamnan polysaccharide based glycoconjugates to prevent disease caused by the dental pathogen Streptococcus mutans.

Authors:  Frank St Michael; Qingling Yang; Chantelle Cairns; Evgeny Vinogradov; Perry Fleming; Alexander C Hayes; Annie Aubry; Andrew D Cox
Journal:  Glycoconj J       Date:  2017-10-02       Impact factor: 2.916

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.